Adenocarcinoma and papilloma adenocarcinoma of rectum

C3_RECTUM_ADENO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C20.92& Cancer registry: Topography ICD-O-3 — C19\|C20 Cancer registry: Morphology ICD-O-3 — 8140 Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	4671
4. Check minimum number of events None	4671
5. Include endpoints None	4671
6. Filter based on genotype QC (FinnGen only)	4213

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF8

NAME	C3_RECTUM_ADENO
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2092
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C19\|C20
CANC_TOPO_EXCL
CANC_MORPH	8140
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papilloma adenocarcinoma of rectum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4213	1581	2632
Unadjusted period prevalence (%)	0.96	0.56	1.21
Median age at first event (years)	68.27	66.97	69.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4355: Matched controls
43538

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A79

ICPC

Malignancy NOS

150.9

321.2

160

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

163.9

319.1

158

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1653.0

313.0

301

WF049

NOMESCO Finland

Radiotherapy of metastasis

925.7

307.7

342

Z51.5

ICD-10 Finland

Palliative care

9.5

307.7

812

1027

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

18.7

307.7

645

402

JFF23

NOMESCO Finland

Transversostomy

258.9

307.7

968

WX402

NOMESCO Finland

General anaesthesia

4.7

307.7

1536

4510

B01AB05

ATC

enoxaparin; parenteral

6.0

307.7

2584

8512

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

338.1

307.7

508

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

135.2

307.7

314

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

521

JN4BD

NOMESCO Finland

Extensive body CT

18.8

307.7

1333

999

WZC30

NOMESCO Finland

Teaching

5.4

307.7

1292

3179

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

16384.0

307.7

2122

B01AB10

ATC

tinzaparin; parenteral

5.7

307.7

877

1837

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

24.0

307.7

2085

1606

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

370.7

307.7

464

L01BC06

ATC

capecitabine; oral

+∞

307.7

1999

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2389

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

106.9

307.7

299

WX600

NOMESCO Finland

Single shot through catheter

73.3

307.7

442

WZC00

NOMESCO Finland

Treatment plan or consultation

4.4

307.7

2160

7943

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.3

307.7

468

557

A03FA01

ATC

metoclopramide; systemic, rectal

17.0

307.7

2252

2575

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

7.0

307.7

534

856

WX408

NOMESCO Finland

General anesthesy, balanced

4.1

307.7

1705

5899

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

704.7

307.7

501

UJF32

NOMESCO Finland

Coloscopy

10.5

307.7

3008

7624

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

27.5

307.7

779

342

JG1CG

NOMESCO Finland

Extensive MRI of rectum

476.7

307.7

579

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

7283.4

307.7

636

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

756

C61

ICD-10 Finland

Malignant neoplasm of prostate

460.9

307.7

417

JFF10

NOMESCO Finland

Loop enterostomy

92.5

307.7

228

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

6614.0

307.7

586

D75

ICPC

Malignant neoplasm colon/rectum

655.6

307.7

619

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.0

307.7

363

327

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

1970.2

307.7

346

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

200.6

307.7

401

WF002

NOMESCO Finland

Radical radiotherapy

150.1

307.7

433

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

517

N02AA05

ATC

oxycodone; systemic

4.1

307.7

1318

4191

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

7161.6

307.7

627

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

488

A04AA01

ATC

ondansetron; systemic, rectal

15.1

307.7

614

468

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2597.5

307.7

486

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3364.8

307.7

323

Z93.3

ICD-10 Finland

Colostomy status

129.4

307.7

564

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

307.7

1037

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

378

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

3706

JN4CD

NOMESCO Finland

Very extensive body CT

17.1

307.7

384

245

WX302

NOMESCO Finland

Thoracal epidural anesthesy

57.4

307.7

1506

397

A04AA02

ATC

granisetron; systemic, transdermal

1246.7

307.7

1114

TPH07

NOMESCO Finland

Cathetrisation of artery

5.5

307.7

1177

2735

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1784.2

307.7

466

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

86.0

307.7

563

JG1BG

NOMESCO Finland

MRI of rectum

729.2

307.7

729

JN4AD

NOMESCO Finland

Body CT examination

14.0

307.7

1460

1509

ZXC96

NOMESCO Finland

Robot assisted procedure

50.8

307.7

290

XX3DW

NOMESCO Finland

Time consuming IT work

14.1

307.7

1009

912

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

631.5

307.7

505

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

504

UJG02

NOMESCO Finland

Proctoscopy

20.3

307.7

582

328

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

89.7

307.7

189

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2714.6

307.7

721

SPAT1125

SPAT

Stoma care and guidance

14.3

307.7

333

251

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

543

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1876.7

307.7

333

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

20.8

307.7

1279

852

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

261.5

307.7

878

H02AB02

ATC

dexamethasone; systemic

94.5

307.7

1345

205

TJF80

NOMESCO Finland

Ostomy education

166.2

307.7

651

C20

ICD-10 Finland

Malignant neoplasm of rectum

16384.0

307.7

1225

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

40.3

307.7

215

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3111.1

307.7

567

JN3AD

NOMESCO Finland

Abdominal CT examination

4.3

307.7

1050

2970

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3812

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

12.2

296.4

304

267

Z43.3

ICD-10 Finland

Attention to colostomy

137.3

290.7

146

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

607.4

290.5

285

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.6

286.9

601

1214

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

2794.4

285.3

273

L03AA02

ATC

filgrastim; parenteral

114.5

282.0

144

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

723.0

278.4

272

ZX070

NOMESCO Finland

Intensity modified radiotherapy

934.8

271.7

264

ZX090

NOMESCO Finland

Other technic of radiotherapy

320.7

267.4

269

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

13.8

263.5

248

189

L02AE02

ATC

leuprorelin; implant, parenteral

49.2

261.9

152

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

253.6

241

A04AA55

ATC

palonosetron, combinations; systemic

+∞

252.6

240

ZXE20

NOMESCO Finland

More than three and less than five hours

3.7

252.0

966

3102

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

1262.6

247.1

239

WF004

NOMESCO Finland

Palliative radiotherapy

2348.1

242.8

233

116

Kela drug reimbursment

Prostate cancer

+∞

239.8

228

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

231.3

220

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

39.2

223.9

137

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

296.4

221.6

224

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

9.8

220.9

261

280

WX306

NOMESCO Finland

Lumbar epidural anesthesy

6.3

220.8

391

669

JF2AB

NOMESCO Finland

Colongraphy with X-ray

75.8

219.6

118

L01BC59

ATC

trifluridine, combinations; systemic

+∞

219.6

209

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

254.8

214.0

218

D99

ICPC

Disease digestive system other

14.6

211.5

192

137

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

47.4

205.2

120

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

201.6

192

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

200.6

191

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

200.6

191

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.7

199.0

504

1185

D18

ICPC

Change in faeces/bowel movements

7.1

198.8

309

461

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.2

198.2

593

1585

C209, 8148, 2

ICD-O-3

95.9

197.6

103

WW500

NOMESCO Finland

Blood transfusion

8.4

194.5

261

329

ZX120

NOMESCO Finland

Intravenous

4.1

193.6

584

1569

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

193.1

184

WF003

NOMESCO Finland

Adjuvant radiotherapy

496.8

192.9

191

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

16.3

186.3

159

101

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

32.2

183.9

119

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

51.2

182.5

105

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

25.6

181.8

127

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.1

179.8

404

858

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

12.4

178.2

178

149

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

9.7

174.9

207

222

JAH00

NOMESCO Finland

Laparotomy

7.1

174.2

272

407

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.6

173.5

641

1977

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

871.9

172.1

168

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

166.9

691

2290

TQW40

NOMESCO Finland

Remowal of suture of skin

4.1

165.3

499

1336

R4110

NOMESCO Finland

Physiotherapy

2.5

163.2

1502

7603

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

69.0

161.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.2

160.6

284

483

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

159.3

152

JFB00

NOMESCO Finland

Partial resection of small intestine

9.9

158.2

185

195

115

Kela drug reimbursment

Breast cancer

+∞

155.1

148

A04AD12

ATC

aprepitant; systemic

769.5

152.2

149

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

13.8

151.3

141

105

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

151.0

1233

5869

PJA12

NOMESCO Finland

Sentinel node biopsy

758.8

150.1

147

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.6

149.9

298

566

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

19.4

149.5

117

L02BG04

ATC

letrozole; oral

30.3

148.8

Z93

ICD-10 Finland

Artificial opening status

223.3

146.9

151

369

Kela drug reimbursment

Regorafenib

+∞

144.6

138

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1439.7

142.5

138

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

140.3

134

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

38.1

139.5

K56.7

ICD-10 Finland

Ileus, unspecified

7.4

138.8

206

291

ZZR00

NOMESCO Finland

Flap of skin

15.1

137.7

122

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

41.8

136.1

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

135.1

129

JGB36

NOMESCO Finland

Wide excision of rectum

1328.5

133.0

129

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.5

132.7

339

796

L03AA13

ATC

pegfilgrastim; parenteral

668.0

132.3

130

Z51.0

ICD-10 Finland

Radiotherapy session

1306.6

130.9

127

176

Kela drug reimbursment

Regorafenib

+∞

130.9

125

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

17.7

127.6

104

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

29.1

124.4

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

14.8

119.6

107

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

119.3

114

B01AB04

ATC

dalteparin; parenteral

4.0

116.6

347

913

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

40.1

116.6

SPAT1262

SPAT

Handing over of treatment supplies

2.3

116.2

1084

5392

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

116.1

111

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

7.2

114.0

173

250

WZC15, ,

NOMESCO Finland

38.4

110.4

JAH01

NOMESCO Finland

Laparoscopy

5.0

109.8

242

502

Z93.2

ICD-10 Finland

Ileostomy status

21.7

108.9

A06AH03

ATC

naloxegol; oral

14.1

105.8

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

105.6

101

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1042.9

104.7

102

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

44.9

104.6

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

23.1

103.4

Y77

ICPC

Malignant neoplasm prostate

182.7

102.8

107

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

23.6

100.1

R4190

NOMESCO Finland

Nutritional therapy

5.4

98.6

201

389

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.1

98.5

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.9

98.3

221

466

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

98.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.3

97.6

168

277

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

20.1

97.5

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

327.5

96.3

L02BA01

ATC

tamoxifen; oral

50.6

95.2

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

95.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.2

94.2

197

390

JFF26

NOMESCO Finland

Sigmoidostomy

41.2

94.2

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

94.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

17.7

92.2

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

91.5

272

713

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

5.6

91.2

178

331

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

315.9

91.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.6

91.0

319

937

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

14.4

90.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.5

88.9

175

328

N02BE01

ATC

paracetamol; systemic, rectal

2.7

87.6

3922

33507

Z43.2

ICD-10 Finland

Attention to ileostomy

135.7

87.3

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.0

87.3

261

687

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

15.1

87.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

86.9

645

2865

WX704

NOMESCO Finland

Intubation

2.9

86.4

445

1646

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.9

85.8

264

709

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

85.7

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

85.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

85.7

1594

10078

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

12.8

85.5

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

844.4

84.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

46.0

84.7

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

20.0

84.4

N03AX16

ATC

[U] pregabalin

2.0

83.3

1118

6307

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

82.5

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.5

82.3

207

478

NK6AN

NOMESCO Finland

Total body bone isotope imaging

21.7

80.7

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

802.9

80.7

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

19.4

80.7

JFF24

NOMESCO Finland

Laparoscopic transversostomy

211.4

80.6

1XC07, ,

NOMESCO Finland

+∞

80.4

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.4

79.6

116

160

E0000UV, ,

ATC

1.8

79.3

1806

12100

XX2RW, ,

NOMESCO Finland

10.2

78.8

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

32.2

78.8

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

782.1

78.6

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

206.2

78.5

Z31.5

ICD-10 Finland

Genetic counselling

4.6

77.7

190

429

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.0

77.4

228

593

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

76.3

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

19.0

76.2

XX1AD

NOMESCO Finland

Other CT-examination

135.8

75.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.7

75.1

120

183

L02BB03

ATC

bicalutamide; oral

+∞

74.2

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.8

74.1

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

16.0

73.5

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

15.0

73.3

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

24.6

71.9

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

71.0

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

31.0

70.2

D16

ICPC

Rectal bleeding

4.4

70.0

182

431

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

352.8

69.8

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.4

69.6

266

824

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

12.8

69.2

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

11.4

69.1

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.9

68.1

153

322

D17

ICPC

Incontinence of bowel

6.6

68.0

110

170

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

342.4

67.7

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

233.6

67.4

K92.1

ICD-10 Finland

Melaena

2.8

67.2

367

1395

JFB30

NOMESCO Finland

Right hemicolectomy

10.0

66.7

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.6

65.9

107

166

TPX15

NOMESCO Finland

Removal of vascular injection port

22.0

64.9

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.9

64.2

195

518

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

637.3

64.0

OAB50, ,

SPAT

2.4

63.8

493

2213

L01EX05

ATC

regorafenib; oral

+∞

63.7

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

63.7

TJG20

NOMESCO Finland

Transanal irrigation

30.3

63.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

219.8

63.3

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

16.1

63.2

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

627.0

63.0

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

627.0

63.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.6

62.9

102

158

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

62.9

2207

16381

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

61.6

L01BC53

ATC

tegafur, combinations; systemic

+∞

61.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

61.0

736

3946

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

60.9

350

1364

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

60.5

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

60.5

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

209.5

60.2

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

129.9

60.0

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

58.5

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

58.5

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.4

58.4

154

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.4

58.4

116

219

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

19.8

58.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

58.1

1236

7947

HAC20

NOMESCO Finland

Total mastectomy

106.5

57.9

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

57.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

57.4

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

195.8

56.1

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

149.5

56.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.8

55.9

132

Z3231

NOMESCO Finland

Registered nurse

1.8

55.3

1165

7451

WGA11

NOMESCO Finland

Planning of pain management

11.5

55.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.5

54.8

107

199

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

18.9

54.4

L01XE21

ATC

[U] regorafenib

+∞

54.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

54.3

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

77.4

54.1

D28

ICPC

Limited function/disability (D)

14.7

53.6

G04BE03

ATC

sildenafil; oral

8.8

53.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

52.9

398

1760

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

52.2

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

182.2

52.0

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.0

51.9

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

18.8

51.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

51.4

908

5495

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

178.7

51.0

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.4

50.0

185

561

HA1AA

NOMESCO Finland

X-ray mammography

3.7

49.2

161

450

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

49.0

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

48.1

162

462

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

48.0

UJF34

NOMESCO Finland

Left colonoscopy

8.3

47.9

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

12.9

47.7

C50.99

ICD-10 Finland

Breast, unspecified

472.8

47.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.1

47.1

130

322

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

76.7

47.0

R50.9

ICD-10 Finland

Fever, unspecified

2.0

46.9

624

3437

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

103.2

46.8

JJB71

NOMESCO Finland

Laparoscopic resection of liver

462.6

46.4

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

46.3

116

267

S18

ICPC

Laceration/cut

1.6

45.7

2012

15348

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.4

44.8

112

257

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

44.8

488

2502

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

58.4

44.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

43.8

D77

ICPC

Malignant digestive neopl other/NOS

118.7

43.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

43.7

125

318

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

6.0

43.6

130

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

42.8

K61.1

ICD-10 Finland

Rectal abscess

12.5

42.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

12.5

42.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

42.6

2720

22417

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

42.5

270

1102

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

42.3

287

1209

V03AF03

ATC

calcium folinate; systemic

421.6

42.2

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

10.3

42.2

JEA00

NOMESCO Finland

Appendectomy

2.6

42.2

248

975

D29

ICPC

Digestive symptom/complaint other

3.7

42.1

136

377

6434

FHL

Anterior resection

79.3

41.9

JJB30

NOMESCO Finland

Excision of two segments of liver

148.1

41.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

41.7

A02BC02

ATC

pantoprazole; systemic

1.6

41.1

2848

23806

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

41.0

1502

10907

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

211.9

40.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

40.7

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.6

40.0

242

965

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

39.6

JHA00

NOMESCO Finland

Anal or perianal incision

5.1

39.2

166

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

38.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

38.6

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.5

38.0

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.6

37.8

199

6435

FHL

Abdominoperineal resection and colostomy

134.5

37.8

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

37.5

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

5.0

37.3

162

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

37.2

327

1539

J01MA12

ATC

levofloxacin; systemic

1.7

37.1

793

5018

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

370.4

37.0

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.1

37.0

106

KA3EB

NOMESCO Finland

Antegrade pyelography

11.6

36.9

JFB43

NOMESCO Finland

Left hemicolectomy

9.6

36.8

JFA70

NOMESCO Finland

Suture of small intestine

12.0

36.8

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

131.1

36.7

ZZR10

NOMESCO Finland

Flap of skin and muscle

12.5

36.6

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

13.1

36.5

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

14.4

36.5

ZXD05

NOMESCO Finland

Urgent procedure

1.6

36.4

1224

8665

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

360.2

36.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

35.8

378

1910

P01AB01

ATC

metronidazole; oral, rectal

1.5

35.5

1473

10913

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

35.5

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

35.5

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

35.5

Z71.8

ICD-10 Finland

Other specified counselling

1.6

35.3

1283

9230

JFB20

NOMESCO Finland

Ileocaecal resection

9.4

35.3

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

350.0

35.0

LEC00

NOMESCO Finland

Partial excision of vagina

78.8

34.8

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

10.1

34.5

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

34.4

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

34.4

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.9

34.4

154

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.2

33.9

137

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

33.9

360

1823

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

45.9

33.7

ZXE00

NOMESCO Finland

One hour or less

1.5

33.6

1443

10739

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

33.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

33.2

228

964

WPB10

NOMESCO Finland

Making a convalescent care decision

12.9

33.1

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

33.0

650

4011

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

33.0

126

390

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.0

32.9

239

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

329.5

32.9

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

35.3

32.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

32.7

510

2939

C209, ,

ICD-10 Finland

+∞

32.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

32.1

686

4326

C209, 8211, 2

ICD-O-3

34.5

31.8

SPAT1153

SPAT

Removal of sutures

1.5

31.7

1269

9281

UKC02

NOMESCO Finland

Cystoscopy

1.7

31.5

727

4674

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

31.3

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

31.3

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

5.8

31.1

100

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

31.0

R19.4

ICD-10 Finland

Change in bowel habit

2.8

30.9

156

567

YX9AW, ,

NOMESCO Finland

315.0

30.9

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

315.0

30.9

JN6AD

NOMESCO Finland

CT of torso and neck

6.1

30.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.5

30.5

109

ZX121

NOMESCO Finland

Central venous catheter

31.0

30.3

L02BX02

ATC

degarelix; parenteral

+∞

30.2

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

30.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

30.2

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

30.2

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

30.2

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

30.2

248

1134

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

11.1

30.2

J01MA02

ATC

ciprofloxacin; systemic

1.5

30.1

1624

12581

JKA20

NOMESCO Finland

Cholecystectomy

2.9

30.0

147

526

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

304.4

29.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

304.4

29.8

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

156.0

29.7

JAD10

NOMESCO Finland

Repair of incisional hernia

5.7

29.5

KC1GB

NOMESCO Finland

Cystography with X-ray

30.2

29.4

JFB46

NOMESCO Finland

Resection of sigmoid colon

5.0

29.3

128

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

29.2

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

29.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

29.0

216

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

33.9

28.7

L02AE04

ATC

triptorelin; parenteral

151.0

28.7

C50

ICD-10 Finland

Malignant neoplasm of breast

151.0

28.7

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

44.0

28.7

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.4

28.5

105

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.2

28.2

112

355

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

28.1

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

28.1

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

28.1

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

28.1

ZX050

NOMESCO Finland

Stereotactic radiotherapy

31.1

28.1

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

64.4

27.9

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

33.0

27.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

27.7

169

676

UJF32, ,

SPAT

2.5

27.7

172

694

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.0

27.7

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

100.7

27.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

100.7

27.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

27.6

1725

13671

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

27.3

309

1599

JFA42

NOMESCO Finland

Endoscopic injection in colon

7.0

27.1

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

38.1

27.1

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

62.4

26.9

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

26.7

281

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.3

26.5

101

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.6

26.3

JFF30

NOMESCO Finland

Other colostomy

29.4

26.3

WPA13

NOMESCO Finland

Palliative consultation

9.5

26.2

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

26.1

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

26.1

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

26.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

26.1

611

3931

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.2

26.0

162

ZX112

NOMESCO Finland

Subcutaneous

5.1

25.9

107

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.1

25.8

176

X76

ICPC

Malignant neoplasm breast female

94.0

25.7

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.6

25.2

129

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

22.7

25.2

A06AD11

ATC

lactulose; oral

1.6

25.2

677

4502

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

25.2

490

3001

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

25.1

158

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.0

25.1

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

25.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

25.0

R33

ICD-10 Finland

Retention of urine

1.8

24.6

434

2585

WX892

NOMESCO Finland

Monitored bed care

1.9

24.4

339

1878

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

56.3

24.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

24.0

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

24.0

KA1FN

NOMESCO Finland

Isotope renography

6.8

23.8

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

31.2

23.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

125.7

23.6

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.1

23.5

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.0

23.4

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

46.9

23.3

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

7.0

23.3

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.9

23.2

102

R03AC02

ATC

salbutamol; inhalant

0.7

23.1

1374

17132

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

22.9

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

22.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

22.9

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

22.9

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

22.9

1XC08, ,

NOMESCO Finland

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

231.1

22.6

LCD00

NOMESCO Finland

Hysterectomy

2.5

22.6

140

565

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.8

22.5

G04CA02

ATC

tamsulosin; oral

1.4

22.5

1311

10171

WX882

NOMESCO Finland

High dependency care

2.6

22.1

130

512

K62.7

ICD-10 Finland

Radiation proctitis

+∞

21.9

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

21.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

21.9

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

21.9

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

21.9

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

221.0

21.6

Z93.8

ICD-10 Finland

Other artificial opening status

221.0

21.6

NET99

NOMESCO Finland

Other operation on pelvis

221.0

21.6

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.2

21.5

174

791

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

21.4

739

10201

XKD00

NOMESCO Finland

Uroflowmetry

1.5

21.3

693

4797

S77

ICPC

Malignant neoplasm of skin

18.9

21.2

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.0

21.2

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

50.2

21.1

WX002

NOMESCO Finland

Sedation and analgesia

1.5

20.9

748

5278

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

60.3

20.9

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

20.8

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

20.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.0

20.8

306

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

20.7

1259

9806

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

210.9

20.6

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

210.9

20.6

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

20.5

767

10448

R11

ICD-10 Finland

Nausea and vomiting

1.8

20.4

311

1771

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

20.4

301

1699

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

20.2

104

383

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

48.2

20.1

M25.5

ICD-10 Finland

Pain in joint

0.7

19.9

660

9213

JAG00

NOMESCO Finland

Repair of other hernia

23.5

19.9

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

18.9

19.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.3

19.9

236

KBH20

NOMESCO Finland

Replantation of ureter

20.8

19.9

TJF80, ,

SPAT

57.8

19.9

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

57.8

19.9

N02BF02

ATC

pregabalin; oral

1.9

19.9

265

1448

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.5

19.8

202

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

19.8

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

19.8

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

19.8

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

19.8

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

19.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

19.8

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

29.0

19.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

105.5

19.6

128

Kela drug reimbursment

Cancers of female genital organs

200.8

19.6

WVA20

NOMESCO Finland

Medicine administration

2.6

19.6

115

453

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

19.3

154

696

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

19.3

461

2967

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

19.3

269

1490

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

19.3

687

9463

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

31.4

19.2

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

18.2

19.1

GDC00

NOMESCO Finland

Lobectomy of lung

22.6

19.0

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

19.0

267

1483

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

18.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

18.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

18.8

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.0

18.7

L02BG03

ATC

anastrozole; oral

70.2

18.7

GDB10

NOMESCO Finland

Wedge resection of lung

27.9

18.7

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

6.8

18.7

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.3

18.4

207

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

18.2

124

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

44.2

18.2

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

18.1

566

8019

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

18.1

161

761

R15

ICD-10 Finland

Faecal incontinence

2.4

18.1

129

556

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.8

17.9

139

K56.0

ICD-10 Finland

Paralytic ileus

3.4

17.9

186

A28

ICPC

Limited function/disability NOS

1.4

17.9

840

6232

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.4

17.8

182

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

17.7

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

17.7

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

17.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

17.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

17.7

G47.3

ICD-10 Finland

Sleep apnoea

0.7

17.6

499

7215

OAA41

NOMESCO Finland

Health check based on individual needs

180.7

17.5

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

180.7

17.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

17.5

195

1004

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

17.4

190

971

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

17.4

566

3907

WX610

NOMESCO Finland

Patient controlled analgesia

6.0

17.3

Z3226

NOMESCO Finland

Physiotherapist

1.5

17.2

646

4591

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

17.1

239

1326

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.6

17.1

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.3

17.0

124

540

WPA44, ,

SPAT

7.5

16.9

N32.1

ICD-10 Finland

Vesicointestinal fistula

7.2

16.9

C10AX09

ATC

ezetimibe; oral

0.6

16.9

408

6114

UJH02

NOMESCO Finland

Anoscopy

2.1

16.9

161

783

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.4

16.8

179

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

16.7

294

1746

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

16.7

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

16.7

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

16.7

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

90.4

16.6

K63.5

ICD-10 Finland

Polyp of colon

2.4

16.5

116

497

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

16.3

16.5

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

13.4

16.4

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

16.4

154

744

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

16.4

153

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

40.2

16.3

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

40.2

16.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

16.2

245

R19.5

ICD-10 Finland

Other faecal abnormalities

2.7

16.2

311

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.2

16.2

100

K83.1

ICD-10 Finland

Obstruction of bile duct

4.0

16.2

113

N02AA01

ATC

morphine; systemic, rectal

2.9

16.1

251

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

3185

18675

3.62

318.30

12.6

19.6

1.19

1.36

inr

68.30

2599

15710

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3194

15486

4.98

307.65

4.2

2.5

—

estimate

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1076

716

19.63

307.65

6.3

1.8

510.24

229.71

u/ml

0.33

997

572

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

515

447

12.93

307.65

5.5

2.0

55.34

24.04

u/ml

3.29

465

406

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1422

2914

6.76

307.65

2.3

2.0

0.21

0.20

g/l

10.36

1391

2655

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1429

3776

5.14

307.65

2.6

2.1

6.97

8.00

umol/l

1.07

1329

3287

(4035726) Immunohistochemistry procedure

1007

936

13.69

307.65

1.4

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1187

3210

4.71

307.65

2.1

2.2

32.32

55.37

u/l

0.87

1079

2666

(3024561) Albumin [Mass/volume] in Serum or Plasma

3193

16422

4.54

307.65

11.1

4.1

33.60

35.45

g/l

61.03

3124

15143

(40768804) Tissue Pathology biopsy report

2282

10815

3.33

307.65

2.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3399

18205

4.95

307.65

15.6

4.0

11.03

12.44

umol/l

8.44

3351

17114

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3524

1973

89.34

307.65

10.6

1.4

34.82

17.21

ug/l

0.53

3231

1489

(3002256) Pathology report gross observation

1080

2752

4.89

307.65

1.3

1.1

—

(3022145) Colonoscopy Study observation

2129

3746

10.16

307.65

1.7

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2102

8110

4.08

307.65

3.6

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

2491

10641

4.13

307.65

3.7

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

1937

8677

3.22

301.67

5.4

3.8

89.36

84.59

15.67

1925

8476

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

780

2255

3.99

235.90

8.9

10.6

16.05

16.10

0.18

765

2181

(3013650) Neutrophils [#/volume] in Blood by Automated count

3035

19083

2.95

232.68

17.6

6.4

3.96

4.41

e9/l

21.11

2657

16195

(3023368) Bacteria identified in Blood by Culture

2057

10874

2.69

217.42

5.3

4.1

—

(3003694) ABO and Rh group [Type] in Blood

1751

8721

2.68

206.16

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1022

3999

3.03

188.09

8.4

8.6

117.70

122.70

g/l

14.04

1004

3914

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2098

11788

2.50

187.24

2.7

2.4

56.81

61.69

u/l

3.47

2030

10835

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2022

11376

2.45

177.17

4.1

2.7

31.30

36.08

u/l

1.77

1975

10599

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3687

27507

3.22

176.04

17.5

5.9

88.85

76.91

u/l

26.73

3614

25677

(3016502) Oxygen saturation in Arterial blood

1056

4390

2.85

172.39

8.2

8.0

97.08

94.95

21.00

1027

4236

(3019977) pH of Arterial blood

1128

4865

2.78

171.57

8.0

7.8

7.41

7.42

3.86

492

2825

(3037121) Protein [Mass/volume] in Urine

477

1202

4.33

171.57

6.4

2.7

208.22

354.53

mg/l

4.69

374

454

(3027801) Oxygen [Partial pressure] in Arterial blood

1120

4885

2.74

166.02

8.1

7.7

14.89

11.49

kpa

65.94

1094

4696

(3014111) Lactate [Moles/volume] in Serum or Plasma

922

3628

2.95

166.01

7.1

7.7

1.20

1.39

mmol/l

5.77

907

3553

(3003396) Base excess in Arterial blood by calculation

1112

4834

2.75

165.89

8.0

7.7

0.53

1.14

mmol/l

6.21

993

3953

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1120

4887

2.74

165.87

8.1

7.7

5.22

5.05

kpa

9.73

1095

4708

(3014007) Fractional oxyhemoglobin in Arterial blood

749

2668

3.18

160.19

8.7

10.0

95.40

93.42

13.70

749

2655

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

671

2366

3.17

145.12

8.7

10.0

23.93

24.33

mmol/l

2.76

666

2307

(3015377) Calcium [Moles/volume] in Serum or Plasma

2004

12029

2.23

141.62

8.6

2.2

2.35

mmol/l

0.40

1889

10556

(3013826) Glucose [Moles/volume] in Serum or Plasma

3115

22378

2.38

141.23

6.6

5.0

6.99

6.89

mmol/l

1.90

3048

21274

(3000991) Gas panel - Venous blood

833

3420

2.77

136.19

8.0

9.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2544

17128

2.17

130.56

8.2

6.1

1.19

1.21

mmol/l

31.48

2412

15552

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1174

5846

2.38

127.06

6.1

2.6

0.79

0.82

mmol/l

19.74

1135

5405

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2740

19164

2.16

125.04

9.0

6.5

1.19

1.21

mmol/l

38.78

2423

16442

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1381

7432

2.26

123.98

9.2

2.2

2.48

2.45

mmol/l

25.52

1300

6549

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

431

1274

3.64

122.69

2.6

3.1

0.30

0.34

iu/ml

1.67

203

731

(3030467) Casts [#/volume] in Urine by Automated count

1728

10657

2.03

104.88

3.8

3.2

0.55

0.46

e6/l

0.70

1310

7790

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

638

2602

2.70

103.67

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1913

12439

1.96

97.86

4.0

3.3

82.25

64.85

e6/l

0.38

1493

9475

(3031040) Bacteria [#/volume] in Urine by Automated count

3071

23696

2.00

91.55

5.2

4.7

632.33

2065.16

e6/l

1.56

373

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1066

5767

2.12

89.87

2.3

2.8

19.99

22.28

6.30

1017

5288

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1130

6277

2.08

88.62

2.3

2.8

2.34

2.27

g/l

3.12

1066

5727

(3022948) Iron [Moles/volume] in Serum or Plasma

1184

6727

2.04

87.08

2.4

2.8

11.52

12.58

umol/l

4.87

1129

6173

(3042936) Bacteria identified in Isolate by Culture

988

5298

2.12

84.60

2.2

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1073

5951

2.06

83.86

3.7

3.0

2.71

2.15

e6/l

0.74

553

2934

(3018095) Leukocytes [#/volume] in Urine

2001

13833

1.83

79.29

4.7

3.8

191.30

117.61

e6/l

2.00

1519

9781

(3026008) Bacteria identified in Urine by Culture

1658

11196

1.78

68.05

3.7

3.4

—

(40758558) Short blood count panel - Blood

1568

10431

1.79

67.64

12.8

4.7

—

(42870588) Differential panel, method unspecified - Blood

1720

11768

1.76

67.24

4.6

5.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1107

6690

1.88

64.92

3.6

2.9

1.02

1.14

e6/l

0.49

589

3680

(40768800) Prostate Pathology biopsy report

120

234

5.24

58.30

1.2

1.1

—

(3026782) Osmolality of Urine

1146

7211

1.80

57.92

3.5

2.9

519.08

534.90

mosm/kgh2o

1.79

1042

6237

(3006504) Eosinophils/Leukocytes in Blood

2160

16208

1.66

56.84

4.9

5.8

2.69

2.99

7.03

2020

14959

(3019069) Monocytes/Leukocytes in Blood

2161

16240

1.66

56.34

5.0

5.9

9.27

9.13

1.08

2022

14985

(3022096) Basophils/Leukocytes in Blood

2156

16238

1.65

55.37

5.0

5.9

0.58

0.66

9.89

2015

14983

(3002030) Lymphocytes/Leukocytes in Blood

2180

16510

1.64

54.40

5.0

5.8

22.69

26.50

42.86

2049

15439

(3000850) Epithelial cells [#/volume] in Urine

1300

8693

1.71

52.02

2.9

2.7

4.90

4.47

e6/l

0.51

1203

7850

(3018418) pH of Serum or Plasma

1582

11215

1.64

50.18

5.0

3.6

7.40

0.21

1055

8026

(3018010) Neutrophils/Leukocytes in Blood

2127

16234

1.61

49.71

4.8

5.7

61.05

58.23

18.94

2029

15336

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1466

10241

1.65

49.02

2.3

2.4

3.17

2.82

mg/l

4.63

1263

8782

(3020779) Urea [Moles/volume] in Serum or Plasma

667

3725

1.93

48.26

5.1

7.3

9.59

11.25

mmol/l

6.55

645

3531

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3860

34645

2.00

45.90

32.8

15.9

38.36

25.55

mg/l

86.21

3683

28500

(40768441) Liver Pathology biopsy report

118

6.45

45.58

1.1

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1033

6796

1.68

42.46

1.9

—

(3001604) Monocytes [#/volume] in Blood

2258

17863

1.55

42.45

4.8

5.5

0.61

0.62

e9/l

0.75

1862

15134

(3006315) Basophils [#/volume] in Blood

2264

17947

1.54

41.98

4.8

5.5

0.04

e9/l

9.47

1876

15226

(3018572) Chloride [Moles/volume] in Blood

220

822

2.76

41.34

8.6

6.9

106.46

104.85

mmol/l

7.10

200

738

(3039000) Anion gap in Blood by calculation

220

822

2.76

41.34

8.6

6.9

10.84

11.45

mmol/l

2.57

200

738

(3048689) Calprotectin [Mass/mass] in Stool

670

3931

1.83

41.06

1.4

2.3

264.10

156.31

ug/g

6.31

531

3126

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

350

1629

2.25

41.03

2.0

1.8

2.60

1.77

ug/l

0.73

316

1419

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

281

1190

2.45

40.90

1.3

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

2284

18258

1.53

39.90

4.9

5.6

1.61

1.82

e9/l

3.22

1942

15824

(3013115) Eosinophils [#/volume] in Blood

2304

18495

1.52

39.16

5.0

5.7

0.18

0.21

e9/l

12.17

1951

15911

(3047181) Lactate [Moles/volume] in Blood

279

1222

2.37

37.65

7.5

5.9

1.34

mmol/l

0.03

248

1087

(3025941) Bacteria identified in Stool by Culture

344

1664

2.16

36.56

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1987

15713

1.49

34.66

2.9

3.1

154.56

140.01

ug/l

0.71

1834

14437

(3008152) Bicarbonate [Moles/volume] in Arterial blood

493

2781

1.87

33.87

8.2

6.9

24.62

24.50

mmol/l

0.31

475

2679

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

628

3836

1.74

33.05

5.1

3.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

447

2474

1.90

32.52

1.8

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

204

831

2.53

32.22

2.0

2.3

3.65

3.58

g/l

0.23

199

786

(3007930) Methemoglobin/Hemoglobin.total in Blood

353

1832

2.01

30.97

6.9

5.0

0.90

0.86

1.42

333

1735

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

132

451

2.99

29.26

1.2

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

607

3801

1.69

28.92

3.3

2.2

252.38

234.06

u/l

1.59

582

3510

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

370

2000

1.93

28.81

6.7

4.8

1.58

1.60

0.16

348

1895

(3019060) Gas panel - Arterial blood

459

2664

1.81

28.56

6.4

4.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

10.06

28.25

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

188

805

2.39

26.66

2.4

1.5

39.39

24.33

u/ml

1.51

183

764

(3003458) Phosphate [Moles/volume] in Serum or Plasma

737

4966

1.58

25.96

4.6

6.0

1.02

1.03

mmol/l

0.49

700

4560

(3021589) Normoblasts [#/volume] in Blood

1905

15524

1.40

25.34

19.3

10.7

0.00

e9/l

0.96

1521

12643

(40768793) Breast Pathology biopsy report

154

4.14

23.35

1.4

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

218

1051

2.13

23.28

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

745

5157

1.54

23.03

1.8

—

(3045142) Bone marrow Pathology biopsy report

160

4.04

23.02

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

995

2.14

22.66

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

855

6114

1.50

22.61

2.0

1.9

29.88

0.01

837

5942

(3019550) Sodium [Moles/volume] in Serum or Plasma

3889

36449

1.62

21.16

40.2

20.3

139.24

139.80

mmol/l

37.79

3843

35689

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

694

4824

1.52

20.86

1.8

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

637

4351

1.54

20.75

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3639

33641

1.50

20.73

35.3

15.6

77.53

74.95

ml/min/173m2

13.36

3482

31232

(3023103) Potassium [Moles/volume] in Serum or Plasma

3892

36520

1.62

20.63

40.4

20.4

3.95

4.01

mmol/l

37.83

3848

35699

(40768795) Lymph node Pathology biopsy report

6.22

20.16

1.3

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

381

5958

0.60

19.21

1.2

1.3

15.50

12.68

u/ml

0.27

134

2225

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

417

6359

0.62

18.88

1.2

1.3

57.51

36.79

iu/ml

1.07

135

1898

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3005

27052

1.36

18.33

3.7

4.5

16.63

12.52

mm/h

28.22

2785

25110

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1282

15730

0.74

17.79

1.9

2.0

1.41

1.33

mmol/l

1.41

1027

12997

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

173

3.50

17.68

1.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

334

2047

1.68

16.93

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2503

22092

1.31

16.57

3.7

3.2

61.32

50.08

u/l

5.70

2366

20328

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

163

807

2.06

16.29

2.2

2.3

219.51

196.81

2.36

156

760

(3027945) Reticulocytes/Erythrocytes in Blood

666

4814

1.45

16.16

2.3

2.0

1.76

1.75

0.07

599

4206

(3004809) Band form neutrophils/Leukocytes in Blood

104

439

2.40

15.35

2.5

2.3

3.20

1.33

2.48

371

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

255

1495

1.75

15.18

2.0

1.8

—

(3012544) pH of Venous blood

619

4465

1.45

15.12

3.2

3.7

7.38

0.17

346

2613

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

14.59

1.0

0.0

—

(40762365) Oxygen content in Arterial blood by calculation

5.41

14.46

4.0

2.3

13.56

15.38

ml/dl

2.61

(3002032) Base excess in Venous blood by calculation

592

4280

1.44

14.23

3.1

3.7

1.83

mmol/l

0.00

506

3759

(3021447) Carbon dioxide [Partial pressure] in Venous blood

606

4404

1.44

14.16

3.1

3.7

5.73

5.82

kpa

1.51

589

4298

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3859

36647

1.46

13.90

21.6

11.0

23.89

25.76

u/l

12.62

3800

35260

(40761536) Microorganisms panel - Urine sediment

390

2605

1.55

13.83

4.8

4.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3045

27894

1.30

13.81

43.8

19.3

14.53

13.68

124.38

3026

27430

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

114

529

2.19

13.53

5.3

6.4

12.16

12.35

mg/l

0.13

486

(3024522) Salmonella sp identified in Specimen by Organism specific culture

428

2.32

13.44

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

234

1389

1.72

13.35

2.0

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

424

2.32

13.28

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

434

2.29

13.03

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

355

2.42

12.90

4.7

3.5

10.36

12.58

index

1.27

165

(3023520) Reticulocytes [#/volume] in Blood

520

3736

1.44

12.87

2.4

2.1

67.27

67.53

e9/l

0.05

372

2785

(3025468) Yersinia sp identified in Specimen by Organism specific culture

405

2.32

12.86

1.4

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3903

37237

1.46

12.79

44.6

21.4

81.20

83.53

umol/l

3.16

3863

36689

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

406

2.29

12.35

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

409

2.28

12.15

1.4

1.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

239

1467

1.67

12.06

4.5

4.1

1.27

1.43

mmol/l

1.59

233

1434

(3021601) Nitrite [Presence] in Urine by Test strip

2191

19468

1.25

11.77

4.6

4.0

0.00

estimate

0.80

527

3900

(3036489) Thrombin time

200

1179

1.73

11.73

1.9

1.8

20.62

20.84

0.32

191

1041

(3012501) Base excess in Blood by calculation

143

765

1.90

11.54

4.5

4.3

2.67

2.70

mmol/l

0.05

105

496

(3042111) Morphology [Interpretation] in Bone marrow Narrative

357

2.32

11.39

1.7

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

416

2934

1.46

11.31

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3306

34963

0.77

11.21

4.8

5.7

4.49

4.44

mmol/l

2.08

3013

32448

(3049717) Cytology report of Urine Cyto stain

224

1379

1.66

11.19

2.7

1.8

—

(3019225) pH of Specimen

504

3694

1.41

11.11

4.4

3.8

7.36

7.35

0.08

403

2445

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

414

2928

1.46

11.09

4.6

3.3

1.22

mmol/l

1.02

368

2469

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

161

909

1.80

10.97

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

162

918

1.79

10.91

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3283

34722

0.78

10.88

4.7

5.6

1.44

1.42

mmol/l

1.46

2977

31991

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3913

37523

1.42

10.77

50.7

24.0

91.48

91.67

1.67

3876

36978

(3035941) MCH [Entitic mass]

3913

37524

1.42

10.76

50.7

24.0

30.19

30.52

22.78

3875

36984

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3913

37525

1.42

10.75

52.1

24.6

38.31

40.48

132.99

3873

36971

(3026361) Erythrocytes [#/volume] in Blood

3913

37526

1.42

10.74

50.8

24.1

4.27

4.49

e12/l

133.28

3824

36414

(3010813) Leukocytes [#/volume] in Blood

3913

37528

1.42

10.72

50.9

24.1

6.77

6.79

e9/l

0.19

3825

36407

(3007461) Platelets [#/volume] in Blood

3912

37519

1.42

10.69

50.9

24.1

247.58

239.28

e9/l

10.64

3836

36582

(3000963) Hemoglobin [Mass/volume] in Blood

3913

37531

1.42

10.68

51.2

24.3

126.80

136.23

g/l

245.25

3875

37001

(42529406) Shigella sp [Presence] in Stool by Culture

162

924

1.78

10.68

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

2206

19744

1.24

10.63

4.7

4.0

11.22

2.89

estimate

0.76

544

4016

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

308

2077

1.52

10.45

2.3

2.5

—

(3009261) Glucose [Presence] in Urine by Test strip

2212

19829

1.23

10.41

4.7

4.0

0.01

0.02

estimate

0.92

518

3674

(3052851) Hemolysis interference index of Serum or Plasma

168

991

1.72

9.88

4.8

3.5

3.28

1.54

index

4.05

109

492

(3023183) Ammonium ion [Moles/volume] in Plasma

150

860

1.77

9.75

2.0

2.6

34.38

34.39

umol/l

0.00

135

766

(1616796) Gas panel - Central venous blood

150

865

1.76

9.56

3.7

4.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

145

832

1.77

9.41

1.3

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

9.37

1.1

0.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

107

561

1.93

9.25

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3152

33329

0.80

9.10

4.1

4.7

1.29

mmol/l

0.04

2819

30353

(3017181) Myelocytes/Leukocytes in Blood

417

3060

1.40

9.10

3.3

3.8

1.20

0.70

4.06

162

658

(3002179) Metamyelocytes/Leukocytes in Blood

402

2937

1.41

9.00

3.2

3.6

0.77

0.55

1.49

159

651

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

409

2.07

8.94

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

348

4786

0.70

8.92

1.2

1.3

491.43

509.68

titre

0.06

1057

(3017354) Segmented neutrophils/Leukocytes in Blood

312

2.23

8.86

2.4

2.3

61.30

59.99

0.19

255

(3043410) Blood group antigens tested for on Red Blood Cells

3.42

8.75

2.4

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

220

1442

1.55

8.54

1.0

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

403

2976

1.39

8.47

3.3

3.8

0.21

0.06

3.06

149

576

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

523

1.91

8.41

1.8

5.5

293.25

892.97

iu/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3274

34387

0.81

8.23

6.6

7.4

40.37

40.47

mmol/mol

0.23

2985

31942

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

975

8163

1.25

8.20

3.5

4.4

695.50

507.09

ng/l

0.43

821

6945

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

223

2.39

8.06

1.2

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

410

3064

1.37

8.01

4.5

2.4

63.45

62.66

ml/min/173m2

0.16

178

1217

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2493

26853

0.83

7.94

3.5

4.1

15.05

14.98

pmol/l

0.67

2213

24309

(3024354) Oxygen [Partial pressure] in Venous blood

485

3737

1.33

7.77

2.8

3.1

4.59

4.49

kpa

0.39

469

3634

(3035715) Granulocytes [#/volume] in Blood

511

1.88

7.67

3.4

3.2

4.17

4.41

e9/l

0.42

511

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

229

2.33

7.62

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

152

2.65

7.53

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

152

2.65

7.53

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

171

2.53

7.40

2.2

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3415

35615

0.81

7.34

5.5

6.6

2.57

2.55

mmol/l

0.53

3100

32984

(4281824) Cell count and differential, peritoneal fluid

178

2.49

7.31

1.3

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3025159) Blasts/Leukocytes in Blood

401

3033

1.35

7.26

3.4

4.0

0.42

0.01

0.56

143

562

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1029

1.60

7.25

1.5

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

166

1068

1.58

7.05

1.3

1.4

247.28

283.98

ug/g

1.31

100

663

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

129

2.73

7.01

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

129

2.73

7.01

1.5

1.3

—

(3017732) Neutrophils [#/volume] in Blood

550

4374

1.29

6.99

5.2

2.9

4.43

4.75

e9/l

0.97

485

3669

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

139

859

1.64

6.97

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

451

1.88

6.87

1.2

1.1

1.65

1.55

g/l

1.07

402

(3035933) Granulocytes/Leukocytes in Blood

104

597

1.76

6.84

3.8

3.1

58.76

59.07

0.07

104

597

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.26

6.74

1.6

2.4

1813.06

5.05

ug/l

0.54

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

128

782

1.66

6.72

1.8

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

363

1.97

6.71

1.3

1.4

214.14

84.13

pmol/l

0.69

348

(21494434) Karyotype in Bone marrow

186

2.38

6.68

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

321

2379

1.38

6.62

3.0

3.6

2.08

1.90

mmol/l

0.36

242

1722

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1567

13995

1.19

6.56

2.7

3.4

1445.18

1569.48

ng/l

0.67

1388

12214

(3017143) Hepatitis C virus Ab [Presence] in Serum

356

2691

1.35

6.49

1.3

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

497

1.81

6.45

1.4

1.5

30.56

28.50

g/l

0.78

433

(3012516) Albumin [Mass/volume] in Urine

1334

15012

0.84

6.45

3.6

3.5

62.65

46.36

mg/l

1.96

917

9859

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.21

6.41

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

3.21

6.41

1.2

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

141

2163

0.64

6.36

1.2

1.3

80.63

59.25

au/ml

—

146

(3009508) Creatinine [Moles/volume] in Urine

1359

15255

0.84

6.35

3.5

7.42

7.52

mmol/l

0.35

1113

12817

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

861

7291

1.23

6.34

1.2

1.3

1.42

1.82

u/ml

0.59

221

1899

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

268

1942

1.40

6.33

1.7

1.5

1.71

1.56

g/l

1.66

234

1663

(3004716) Salmonella sp identified in Stool by Organism specific culture

185

1251

1.50

6.30

1.2

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

223

3118

0.70

6.26

1.3

1.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

6.25

1.0

0.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

186

2.32

6.23

1.7

1.8

2.65

1.82

u/field

0.43

121

(1002224) Polysomnography panel

1315

0.55

6.23

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1669

1.43

6.22

1.2

1.4

—

(40765096) Chromosome analysis panel by Banding

4.11

6.08

1.3

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

275

2.05

5.96

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

323

1.96

5.95

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

366

1.90

5.91

1.4

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

130

827

1.59

5.85

2.8

2.7

15.46

16.56

3.30

130

810

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1184

13374

0.84

5.83

2.2

2.3

207.06

240.29

u/l

0.66

1127

12534

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

132

2.51

5.68

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

132

2.51

5.68

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

132

2.51

5.68

1.4

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1374

15297

0.85

5.62

4.3

10.34

8.12

mg/mmol

1.17

893

9732

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

363

2815

1.32

5.57

3.2

3.7

5.10

5.16

kpa

0.67

341

2670

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

325

1.92

5.52

1.3

353.62

306.71

u/l

0.18

305

(3011397) Hemoglobin [Presence] in Urine by Test strip

1077

9443

1.19

5.38

3.5

3.9

0.20

0.19

—

124

(3009343) pH of Capillary blood

352

2733

1.31

5.36

3.2

3.7

7.42

0.01

296

2271

(3015736) pH of Urine

1719

15659

1.16

5.31

3.8

3.5

6.15

6.25

3.05

857

8491

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

165

2361

0.69

5.30

2.2

2.5

50.48

21.98

au/ml

—

180

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.79

5.29

1.4

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

2.43

5.19

1.4

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

13.35

5.07

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

1124

9936

1.18

5.05

3.5

3.0

0.05

0.00

322

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.89

4.94

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

201

2.10

4.85

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

384

1.78

4.84

1.5

24162.73

61866.35

e6/l

0.89

215

(3000012) Reticulocyte production index

565

1.64

4.84

2.2

1.6

0.90

0.86

0.26

361

(3023199) Leukocytes [#/volume] in Pleural fluid

436

1.73

4.84

1.5

894.96

2711.28

e6/l

2.03

310

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

11.44

4.78

1.3

1.9

190.63

180.86

umol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

118

1764

0.66

4.78

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

273

1.92

4.67

2.9

2.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.65

4.64

1.5

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.65

4.64

1.5

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

192

2.09

4.60

1.4

—

(1761868) Lipid panel - Serum or Plasma

1063

11923

0.86

4.56

3.2

3.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

355

2823

1.28

4.54

2.6

3.2

123.49

130.58

g/l

7.00

344

2739

(4094501) Cardiovascular stress test using bicycle ergometer

1145

0.60

4.45

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

571

0.43

4.41

4.3

4.7

344.07

346.17

umol/l

0.02

493

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

239

1.93

4.28

1.3

10.85

11.48

u/l

0.12

212

(3026493) Urate [Moles/volume] in Serum or Plasma

918

10370

0.85

4.28

2.7

2.6

360.36

361.60

umol/l

0.12

803

8923

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1735

15991

1.14

4.27

3.9

4.2

62.85

86.14

ng/l

0.33

1421

12236

(3029937) Albumin [Presence] in Urine by Test strip

1243

11197

1.15

4.26

5.0

4.2

0.01

0.00

estimate

0.27

452

3547

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

199

1473

1.37

4.24

3.0

4.0

24.88

24.82

mmol/l

0.09

176

1328

(3005322) IgE [Units/volume] in Serum or Plasma

152

2115

0.71

4.23

1.2

1.3

232.62

263.07

u/ml

0.21

136

1965

(3007164) IgA [Mass/volume] in Serum or Plasma

709

6128

1.19

4.10

1.5

1.3

2.65

2.73

g/l

0.35

393

3479

(3008898) HLA-B27 [Presence]

841

0.55

4.05

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

332

1.76

4.01

1.2

1.3

6.78

6.63

mmol/l

0.16

297

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.43

3.96

1.3

1.4

1.55

2.34

0.52

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

305

1.78

3.91

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

108

730

1.49

3.83

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

352

1.71

3.83

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

453

1.62

3.77

1.9

1.8

88.43

89.66

0.78

446

(3023487) Leukocytes [#/volume] in Peritoneal fluid

114

2.29

3.77

1.3

2.5

707.47

616.68

e6/l

0.10

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

350

0.34

3.75

1.0

1.1

—

(3011648) Oxygen content in Venous blood

431

1.63

3.74

1.3

2.1

11.29

10.61

0.63

431

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

661

1.51

3.73

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

1.88

3.67

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.42

3.63

1.3

2.3

22825.50

27267.47

e6/l

0.05

(3021960) Folate [Moles/volume] in Serum or Plasma

1338

12226

1.14

3.62

1.8

1.7

19.86

20.03

nmol/l

0.16

1146

10232

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.51

3.60

2.4

1.1

1.20

3.24

ug/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

767

1.46

3.55

1.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

448

1.59

3.46

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

316

3862

0.80

3.45

1.3

1.4

—

(3022313) Gas panel - Capillary blood

244

1923

1.28

3.42

3.2

3.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

139

1010

1.39

3.39

3.1

7.92

7.88

kpa

0.09

134

985

(3045414) Leukocytes [Presence] in Urine

453

3826

1.21

3.39

3.5

2.0

0.00

0.01

estimate

0.78

753

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3371

34692

0.87

3.38

5.0

5.8

6.14

6.10

mmol/l

1.02

3048

31585

(3044007) Cell count panel - Peritoneal fluid

2.32

3.33

1.3

2.0

—

(3017569) Oxygen content in Arterial blood

284

1.73

3.31

2.2

1.8

15.50

16.38

1.17

284

(3044242) Glucose [Moles/volume] in Arterial blood

262

1.76

3.30

2.2

1.7

8.20

8.42

mmol/l

0.08

262

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

339

1.66

3.24

3.2

2.9

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

824

0.60

3.24

1.2

1.3

7.29

23.64

e6/l

1.06

618

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

834

0.61

3.20

1.2

1.4

3897.11

923.32

e6/l

0.36

667

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

371

1.63

3.20

1.2

1.1

—

(3035880) pH of Pleural fluid

186

1.89

3.14

1.2

1.3

7.48

7.42

1.43

122

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1213

0.68

3.12

1.2

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

111

791

1.41

3.06

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

791

1.41

3.06

1.2

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1078

0.66

3.06

1.5

0.86

3.41

iu/ml

0.42

216

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.23

3.05

1.5

1.8

12.17

13.69

g/l

0.42

(4034850) Laboratory test

1294

0.70

2.96

12.0

10.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

799

7145

1.14

2.94

4.4

4.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

272

1.70

2.93

1.4

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

272

1.70

2.93

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

272

1.70

2.93

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1070

9754

1.13

2.92

4.8

3.5

0.00

0.19

estimate

0.93

408

2997

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

549

1.48

2.92

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1181

0.69

2.87

1.5

1.9

42.34

44.03

nmol/l

0.36

1137

(3030981) Hyaline casts [#/volume] in Urine by Automated count

402

3415

1.19

2.85

3.1

2.3

0.51

0.44

e6/l

0.35

391

3281

(3005532) Lymphocytes/Leukocytes in Pleural fluid

123

2.04

2.80

1.2

1.4

43.86

63.82

1.42

103

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1338

0.71

2.80

1.2

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

792

0.63

2.79

1.2

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.45

2.79

1.0

1.1

8.70

9.02

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.45

2.79

1.0

1.1

22.00

21.79

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.45

2.79

1.0

1.1

36.10

35.84

—

(3028707) Methadone [Presence] in Urine by Screen method

205

0.34

2.78

1.0

2.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

136

1792

0.75

2.77

1.9

3.42

3.44

mmol/l

0.04

1310

(21494755) Public health laboratory ask at order entry panel

142

1854

0.76

2.72

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

234

1892

1.25

2.71

4.5

2.0

0.00

0.44

estimate

0.51

575

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1340

0.72

2.70

1.2

6.02

0.69

u/ml

—

117

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

310

1.62

2.69

1.0

1.1

3.07

2.73

eliau/ml

0.10

116

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

999

0.68

2.67

1.3

1.7

4.84

5.16

mg/l

0.07

746

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.75

2.67

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

350

1.58

2.67

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

763

1.39

2.64

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

307

0.42

2.63

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

408

3501

1.18

2.60

1.4

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

321

1.60

2.60

1.8

2.1

2.54

1.45

u/field

0.70

172

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.13

2.54

1.4

1.3

851.43

4.59

ug/l

0.56

(3019832) Treponema pallidum Ab [Presence] in Serum

1185

0.71

2.52

1.3

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3177

32655

0.90

2.51

4.4

5.2

2.04

2.01

mu/l

0.35

2832

29815

(3007566) Smooth muscle Ab [Titer] in Serum

121

908

1.34

2.50

1.1

1.2

170.00

124.82

titre

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.20

2.47

3.6

2.4

1.67

1.14

0.72

(3027273) Bicarbonate [Moles/volume] in Venous blood

255

2106

1.22

2.46

3.3

3.2

24.58

25.25

mmol/l

1.80

241

2034

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.14

2.44

1.2

—

(3000494) Fungus identified in Specimen by Culture

500

4390

1.16

2.40

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

676

1.38

2.37

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

100

737

1.36

2.34

1.0

1.1

1.21

10.53

eliau/ml

—

(36660697) Celiac disease serology panel - Serum

307

2596

1.20

2.34

1.1

1.2

—

(3036603) Volume of Urine

237

1.65

2.31

2.0

1.4

1806.92

1914.04

0.37

226

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1220

0.73

2.28

1.2

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.48

2.26

1.1

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

391

0.53

2.22

1.5

35.17

28.14

0.28

259

(3006184) Hemoglobin [Mass/volume] in Capillary blood

134

1044

1.29

2.17

2.5

2.2

124.41

131.05

g/l

2.16

105

831

(3000475) Leukocytes [#/volume] in Synovial fluid

1126

0.73

2.13

1.4

1.5

7228.88

14008.39

e6/l

1.60

798

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

953

0.71

2.13

1.2

1.3

2.89

4.83

u/ml

—

142

(3023420) DNA double strand Ab [Units/volume] in Serum

114

1474

0.77

2.10

1.4

1.6

4.95

6.58

iu/ml

0.46

360

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

607

1.37

2.08

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

431

3793

1.15

2.03

2.4

3.2

224.65

231.97

ng/l

0.12

392

3497

(3014891) Appearance of Pleural fluid

2.40

2.02

2.1

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

144

0.35

2.01

4.2

2.9

29.80

29.35

umol/l

—

105

(3042631) Mycobacterium sp identified in Specimen

484

1.41

2.00

1.8

3.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

414

0.58

1.98

1.3

17092.00

213493.21

e6/l

4.51

285

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

950

0.72

1.97

1.2

11.02

5.84

u/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

1400

0.77

1.93

1.6

1.5

0.38

0.32

mg/l

0.46

646

(4212803) Bone marrow aspirate examination

3.18

1.88

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.18

1.88

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.31

1.87

1.0

1.2

79.27

155.21

ng/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

250

0.48

1.83

1.4

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

4.17

1.82

3.0

2.8

77.80

56.72

pmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

278

1.52

1.81

2.5

2.8

28.95

35.76

mg/l

0.61

207

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

182

0.44

1.80

1.0

6.2

—

847.31

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1832

17500

1.08

1.77

5.2

4.4

2.58

2.07

ug/l

1.97

1611

15842

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

375

0.58

1.77

1.1

—

0.28

—

(3013637) Mi-2 Ab [Presence] in Serum

134

0.37

1.75

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

134

0.37

1.75

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

134

0.37

1.75

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

134

0.37

1.75

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

483

0.64

1.73

1.4

1.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.67

1.72

1.0

1.2

22.22

14.69

g/l

—

(3016879) Cocaine [Presence] in Urine

421

0.62

1.71

1.0

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

214

2520

0.84

1.71

2.1

2.2

3.43

3.49

ratio

0.35

173

2051

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

103

1.85

1.71

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

517

0.65

1.70

1.5

61.60

60.94

0.03

343

(3035637) Corticotropin [Mass/volume] in Plasma

316

1.46

1.68

1.4

31.09

24.63

ng/l

0.38

316

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

657

0.70

1.67

1.1

1.2

0.65

0.63

ratio

0.14

117

(3040151) Glucose [Moles/volume] in Capillary blood

486

1.36

1.64

6.0

21.0

6.67

7.49

mmol/l

2.25

406

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

204

1.57

1.64

1.5

1.4

11.11

8.27

u/l

0.37

163

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

354

0.59

1.64

1.1

—

25.21

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

735

0.72

1.63

1.2

1.52

g/l

0.06

735

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

221

1.54

1.61

1.9

2.1

58.89

231.10

ug/min

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.93

1.54

1.4

16.56

27.55

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.86

1.50

1.3

1.6

—

(3014271) Vancomycin [Susceptibility]

234

1.50

1.48

2.7

2.9

—

(3024263) Appearance of Synovial fluid

216

0.51

1.46

1.2

1.6

—

(3019150) Specific gravity of Urine by Refractometry

850

9096

0.92

1.46

4.2

4.3

1.02

1.19

kg/l

0.51

609

5991

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

460

5070

0.90

1.45

10.9

7.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

195

1.54

1.45

2.8

1.4

172.60

1869.51

u/l

0.66

(3020876) Protein [Mass/time] in 24 hour Urine

489

1.33

1.45

2.6

2.1

0.77

1.37

g/24h

2.16

266

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

911

0.76

1.45

1.2

—

29.06

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.12

1.44

2.2

1.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.13

1.44

1.0

2.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.73

1.43

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

340

0.62

1.43

1.0

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

196

1.53

1.42

1.1

83.03

80.27

u/l

0.08

168

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

138

0.43

1.39

1.0

1.1

—

9.40

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

180

0.50

1.39

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

275

0.58

1.38

1.2

1.4

183.72

202.61

pmol/l

0.21

275

(3027008) Opiates [Presence] in Urine

445

0.67

1.38

1.0

1.9

—

(3047189) Immunofixation for 24 hour Urine

142

1.62

1.38

1.8

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1104

0.79

1.37

2.5

2.2

175.64

119.32

ug/min

0.35

642

(3000492) Spirometry study

291

3283

0.88

1.37

1.4

1.5

—

(3001729) Color of Synovial fluid

0.00

1.34

0.0

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

120

1.67

1.33

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

1.33

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.78

1.32

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.04

1.32

1.3

7.83

1.24

mmol/l

—

(3006245) CD3-CD19+ cells/cells in Blood

1.97

1.32

1.3

1.8

22.33

8.73

1.13

(40758292) HTLV I+II Ab panel - Serum

2.50

1.30

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.78

1.28

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

281

0.60

1.28

1.2

2.65

2.20

mmol/l

0.60

264

(3006442) Creatine [Moles/volume] in Serum or Plasma

251

1.44

1.28

1.3

1.7

88.00

92.08

umol/l

0.38

251

(3013166) Neutrophils/Leukocytes in Synovial fluid

133

0.45

1.27

1.2

1.3

41.83

57.27

—

116

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

2.00

1.27

1.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

130

1.62

1.26

1.2

2.0

16.43

17.13

0.11

125

(3028300) Cannabinoids [Presence] in Urine

447

0.69

1.25

1.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

312

1.38

1.23

2.0

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

253

1.43

1.23

1.2

1.5

—

(1175426) CD3 cells/Lymphocytes in Blood

139

1.59

1.22

1.2

2.0

65.41

72.31

1.03

128

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

149

1749

0.85

1.22

1.2

179.37

126.42

u/ml

0.71

643

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

409

0.68

1.22

1.3

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

444

0.70

1.22

1.0

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

105

862

1.22

1.21

1.4

1.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

196

1.48

1.21

1.1

27.79

22.42

u/l

0.31

165

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

214

0.56

1.21

1.1

—

(3000330) Specific gravity of Urine by Test strip

238

2098

1.14

1.19

5.4

3.3

1.02

ratio

0.05

216

1905

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

810

1.23

1.19

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

440

0.70

1.17

1.0

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

133

1.58

1.17

1.2

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.16

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

102

1.67

1.16

1.4

1.7

0.00

0.12

estimate

1.35

102

(3048879) Bone marrow aspiration report

1.85

1.13

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

1.85

1.13

1.3

1.8

27.50

25.32

0.20

(3005033) Fetal Nuchal fold Thickness US

1.96

1.11

1.3

1.5

1.27

1.30

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.71

1.11

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

152

1.52

1.08

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.19

1.08

1.1

1.2

—

0.09

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.92

1.06

1.3

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

831

7850

1.07

1.05

1.7

2.14

1.28

mg/l

4.27

685

6149

(4015189) Microbial culture of sputum

123

0.49

1.05

1.3

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

325

3573

0.90

1.03

1.6

1.8

1.57

0.06

278

3039

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

106

1.61

1.02

2.5

32.78

44.36

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

545

1.25

1.02

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

299

0.67

1.02

1.1

2.7

—

(4133840) Spirometry

1.69

1.01

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

290

1.35

1.01

1.1

—

(3000285) Sodium [Moles/volume] in Blood

107

0.47

1.01

1.0

1.3

136.60

138.81

mmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

107

0.47

1.01

1.2

1.5

10.62

9.95

ug/l

—

107

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

310

0.68

1.00

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

983

0.82

1.00

1.5

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

181

1.44

0.98

2.2

1.9

—

(3037756) Immunofixation for Serum or Plasma

794

1.20

0.97

1.6

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

913

0.82

0.96

2.1

1.9

11.80

12.09

mg/l

0.11

851

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1519

14656

1.06

0.96

4.8

4.0

0.01

0.10

estimate

1.17

425

3156

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

174

0.57

0.96

1.3

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.96

0.0

1.5

—

0.73

—

(3016018) Differential panel - Cerebral spinal fluid

388

0.72

0.96

1.1

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.95

0.0

1.1

—

79.53

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

337

1.31

0.95

2.0

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

444

0.74

0.94

1.1

2.24

1.34

u/ml

0.31

241

(3045683) HLA typing for celiac disease panel - Blood or Tissue

133

1.51

0.94

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.61

0.93

2.7

2.2

7.97

7.96

mmol/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

131

1512

0.86

0.93

1.8

40.15

38.43

u/l

0.39

120

1287

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

1.40

0.93

1.1

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

209

1.39

0.92

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.82

0.92

1.4

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.92

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

508

1.24

0.92

1.6

1.5

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.07

0.89

13.0

12.2

0.20

0.19

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

359

0.72

0.89

1.1

2.73

3.30

u/ml

0.22

167

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

202

1.39

0.89

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

237

1.35

0.87

2.5

2.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

369

1.28

0.86

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

441

1.25

0.85

1.2

1.5

170.31

157.53

au/ml

0.43

148

(3002523) Influenza virus A Ag [Presence] in Specimen

370

1.27

0.85

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

114

984

1.16

0.83

2.5

2.7

1.87

1.79

mg/l

0.37

102

851

(44790049) Parainfluenza type 3 nucleic acid detection

425

1.25

0.83

1.2

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

425

1.25

0.83

1.2

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

425

1.25

0.83

1.2

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

425

1.25

0.83

1.2

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

459

4906

0.93

0.81

4.8

5.5

32.76

32.95

0.13

284

3206

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.88

0.81

1.0

1.1

7.33

10.03

u/l

—

(3025130) Human papilloma virus identified in Specimen

223

1.35

0.81

1.5

1.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

352

0.74

0.80

1.1

1.41

0.76

u/ml

0.55

140

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.70

0.80

2.3

2.7

0.50

0.38

u/field

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

164

0.61

0.80

2.1

2.4

55.90

57.47

umol/l

—

141

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.79

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

8.70

—

(3005719) IgG [Mass/volume] in Serum or Plasma

257

2346

1.10

0.78

2.7

2.3

9.91

10.89

g/l

3.43

239

2163

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.1

—

0.03

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1819

17712

1.05

0.77

2.3

2.4

—

(3019174) dRVVT (LA screen)

0.00

0.77

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

337

0.74

0.76

1.1

1.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.5

—

0.72

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.54

0.75

1.4

1.6

1133.77

1012.15

mu/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

201

1.35

0.74

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

776

0.83

0.73

1.4

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.64

0.73

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

133

0.60

0.73

1.1

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

142

0.63

0.69

1.4

1.9

95.62

50.96

ug/l

—

137

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

216

0.69

0.68

1.5

2.1

17.41

15.42

nmol/l

0.38

191

(21494890) Protein electrophoresis panel - 24 hour Urine

373

1.24

0.68

2.5

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.56

0.68

1.2

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2878

28353

1.04

0.68

43.9

20.9

329.74

332.39

g/l

44.09

2859

28184

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

143

1277

1.12

0.68

3.2

1.5

3.76

1.61

ratio

0.65

731

(21491868) Cryoglobulin [Mass/volume] in Serum

118

0.59

0.67

1.3

1.2

—

0.06

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

811

0.85

0.67

1.7

1.8

5.49

11.53

iu/l

0.35

301

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

226

0.71

0.66

1.1

0.12

0.27

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

281

3029

0.92

0.65

1.5

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

461

0.80

0.65

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.57

0.65

1.3

1.2

1.89

1.40

mmol/l

—

(3021788) Differential panel - Synovial fluid

797

0.85

0.65

1.3

1.5

—

1.00

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

548

0.82

0.65

1.4

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

103

1.46

0.64

1.8

1.4

13.21

17.09

pmol/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

166

0.66

0.64

1.1

0.96

1.15

u/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.72

0.64

1.0

1.1

—

16.44

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

128

0.62

0.63

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

561

1.18

0.63

1.2

1.3

40.51

30.08

iu/l

1.45

480

(3006270) Folate [Moles/volume] in Blood

347

0.78

0.62

1.3

1.2

366.16

349.87

nmol/l

0.15

278

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

814

0.86

0.61

1.2

6.84

3.43

u/ml

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.60

0.61

1.0

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.60

0.61

1.4

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.60

0.0

1.4

—

0.13

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

159

1442

1.11

0.60

3.2

1.5

35.95

mg/l

0.00

137

1208

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

255

0.74

0.60

1.1

1.2

0.09

1.01

u/ml

1.70

151

(3038177) Helicobacter pylori Ab [Presence] in Serum

454

1.19

0.59

1.2

1.3

—

(4146454) Self-monitoring of blood glucose

519

1.18

0.59

3.3

2.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

421

0.81

0.58

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.58

0.0

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.58

0.0

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

159

1445

1.10

0.58

3.2

1.5

58.72

48.69

mg/l

0.71

138

1216

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.71

0.57

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

219

0.73

0.57

1.1

1.0

—

(3025577) Chromium [Mass/volume] in Blood

309

0.78

0.57

2.3

2.1

2.77

1.84

ug/l

0.79

255

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.57

0.56

1.0

1.2

1.32

58.25

mg/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

240

0.75

0.55

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

395

4172

0.94

0.55

2.0

2.5

6.74

7.60

ug/l

0.40

338

3686

(3016650) Hepatitis A virus Ab [Presence] in Serum

440

1.18

0.54

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

273

0.77

0.54

1.1

3.86

2.33

u/ml

—

128

(3051387) C reactive protein [Mass/volume] in Capillary blood

824

0.87

0.53

3.6

3.7

34.40

28.82

mg/l

0.51

582

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

1.33

0.52

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.43

0.52

1.3

—

(3044941) Cell count panel - Synovial fluid

779

0.87

0.52

1.3

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

462

1.17

0.51

1.2

2.82

5.56

u/ml

1.61

215

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

109

1.38

0.50

1.7

2.4

0.64

0.62

mmol/l

0.54

109

(3024869) Neuronal Ab [Presence] in Serum

1.47

0.50

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

145

0.69

0.50

1.1

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.46

0.50

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

463

1.17

0.50

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

302

0.79

0.49

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

557

1.15

0.49

1.3

51.57

77.04

mu/l

0.92

499

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1028

0.89

0.49

1.4

1.5

0.26

0.24

g/l

1.44

978

(3018333) Ribosomal P Ab [Presence] in Serum

234

0.77

0.48

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

366

0.82

0.48

1.1

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

229

2448

0.93

0.47

1.2

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

128

1.33

0.47

1.6

2.4

4.82

5.07

kpa

0.54

128

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

128

1.33

0.47

1.6

2.4

9.59

10.00

kpa

0.37

128

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

522

1.15

0.47

1.3

310.91

295.93

pmol/l

0.08

439

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

466

1.16

0.47

1.2

4.09

2.97

u/ml

0.23

147

(4062490) Immunoglobulin typing, IgG

354

0.82

0.47

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.46

0.46

1.3

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.60

0.45

1.2

1.3

163.80

248.24

pmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

638

1.13

0.44

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

491

0.85

0.44

1.1

1.2

231.55

202.38

miu/ml

—

174

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.65

0.42

1.0

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1897

18662

1.03

0.41

2.3

2.2

87.83

94.16

pmol/l

7.43

1143

9919

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.41

0.0

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

271

0.81

0.40

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.36

0.40

1.2

16.76

15.33

umol/l

0.83

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

411

0.85

0.39

3.2

3.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

232

1.21

0.39

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

0.67

0.39

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

165

1762

0.93

0.36

3.1

3.0

4.34

4.43

pmol/l

0.64

152

1545

(21494814) CD8 cells/Lymphocytes in Specimen

1.39

0.36

1.0

2.2

23.90

24.28

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.27

0.36

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.31

0.35

5.1

1.1

40.94

62.98

u/ml

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

363

0.85

0.35

1.5

1.4

0.31

0.41

g/l

1.53

267

(3028192) IgG subclass 2 [Mass/volume] in Serum

363

0.85

0.35

1.5

1.4

2.35

2.97

g/l

1.86

264

(3027135) IgG subclass 1 [Mass/volume] in Serum

363

0.85

0.35

1.5

1.4

6.00

6.97

g/l

0.88

265

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

282

1.17

0.35

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

255

0.82

0.35

1.0

1.1

2.34

3.53

u/ml

—

102

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

298

0.84

0.34

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

110

1016

1.08

0.34

5.1

4.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

317

3033

1.05

0.34

2.0

1.8

405.46

371.30

nmol/l

2.11

299

2750

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

291

3045

0.95

0.34

3.4

4.0

94.81

98.64

ng/l

0.27

238

2573

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

803

0.91

0.33

1.3

1.5

1.11

0.83

nmol/l

1.11

663

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

510

1.12

0.33

1.2

1.5

—

(3023419) Bacteria identified in Sputum by Culture

561

0.89

0.32

2.3

2.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.35

0.32

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

306

0.85

0.32

1.1

1.89

0.98

u/ml

0.36

147

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

359

0.86

0.32

1.0

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

137

1.24

0.32

1.9

1.2

12.91

8.52

umol/l

0.22

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1396

14187

0.98

0.31

4.3

4.1

20.53

24.42

18.67

701

7054

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.73

0.30

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.71

0.30

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.30

0.30

1.0

1.1

60.00

67.28

ug/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

138

1.23

0.30

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

291

3033

0.96

0.30

1.9

2.3

11.47

15.13

nmol/l

9.59

250

2724

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

115

1231

0.93

0.29

3.3

1.4

0.00

g/l

-0.00

102

1088

(3002079) Sodium [Moles/time] in 24 hour Urine

163

0.80

0.29

1.3

1.2

176.85

173.77

mmol/24h

0.02

163

(40759836) Histone Ab [Presence] in Serum by Immunoblot

260

0.85

0.29

1.1

—

(44806420) Estimation of glomerular filtration rate

324

0.86

0.29

2.4

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

576

0.90

0.28

1.4

1.7

0.96

0.89

g/l

0.10

448

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

184

0.81

0.28

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.29

0.28

1.0

2.3

2.74

2.70

ratio

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

117

0.77

0.27

1.1

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

427

0.89

0.27

1.1

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

168

1.19

0.27

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

1543

0.94

0.27

2.9

1.4

10.38

10.12

g/l

0.30

122

1342

(3004775) Volume in Urine collected for unspecified duration

342

0.88

0.26

1.8

2.3

671.39

627.29

0.37

225

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

257

0.86

0.26

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

257

0.86

0.26

1.1

—

(4195642) Thrombophilia screening test

434

1.11

0.25

1.2

—

(3016228) CD19 cells/cells in Blood

1.22

0.25

1.0

2.1

9.89

8.19

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

145

1528

0.95

0.25

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

121

1282

0.94

0.25

3.5

1.4

0.01

g/l

0.16

108

1164

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.71

0.24

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

648

1.08

0.24

1.2

112.80

18.52

u/l

1.09

552

(3044927) Protein electrophoresis panel - Urine

463

0.91

0.23

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

767

7812

0.98

0.22

1.7

1.8

1168.44

1143.43

nmol/l

0.28

582

5932

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.74

0.22

4.3

7.3

10.61

10.17

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.22

0.22

1.2

1.5

56.40

46.63

umol/l

—

(40768797) Stomach Pathology biopsy report

522

5099

1.03

0.22

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.20

—

(3034426) Prothrombin time (PT)

104

0.77

0.21

1.1

1.2

27.00

28.77

—

104

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.16

0.21

1.0

1.1

—

(4268621) Lupus anticoagulant assay

325

1.11

0.21

2.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

1.75

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

30.41

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

0.10

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

402

1.10

0.20

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

1346

1.05

0.20

2.0

2.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

261

0.88

0.20

1.5

1.2

110.96

99.70

pmol/l

0.60

261

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.22

—

(3006462) Nitrate [Presence] in Urine

164

1.16

0.20

4.2

3.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

250

0.88

0.20

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

111

1166

0.95

0.19

3.4

1.4

0.00

g/l

-0.00

101

1084

(4211845) Urine protein measurement

184

1.14

0.19

4.0

3.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

100

1053

0.95

0.19

1.4

1.5

1.19

g/l

0.05

999

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

443

1.08

0.19

1.2

1.3

0.20

nmol/l

0.04

371

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

137

1.17

0.18

1.8

1.7

0.53

0.69

e9/l

1.05

129

(3020630) Protein [Mass/volume] in Serum or Plasma

356

3471

1.03

0.18

2.7

1.6

64.99

66.50

g/l

2.90

320

3118

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

629

1.07

0.17

1.2

—

0.78

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

157

1.15

0.17

1.1

1.3

5.98

6.22

mmol/l

0.47

148

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

131

0.84

0.17

1.0

1.2

—

(3022621) pH of Urine by Test strip

306

2983

1.03

0.16

3.1

2.7

6.05

6.03

0.10

240

2092

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.16

0.16

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.11

0.16

1.0

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

191

1850

1.03

0.16

2.2

1.4

1.48

1.17

g/l

0.76

178

1691

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

111

1.17

0.15

1.1

1.2

—

1386039.80

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.78

0.15

1.2

—

(3033099) Centromere Ab [Titer] in Serum

0.78

0.15

1.0

1.2

—

(3003181) Sodium [Moles/volume] in Urine

789

1.05

0.15

1.6

1.4

68.78

60.29

mmol/l

0.76

634

(3036071) Salmonella sp Ab [Titer] in Serum

0.76

0.15

1.3

1.1

—

(3004451) EKG impression Narrative

264

1.10

0.15

1.2

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1776

0.97

0.15

2.9

1.4

3.70

3.77

g/l

0.29

149

1586

(3025018) Bordetella pertussis Ab [Titer] in Serum

161

0.87

0.15

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1785

0.97

0.15

2.9

1.4

7.44

7.47

g/l

0.11

150

1594

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

171

0.88

0.14

1.0

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.79

0.14

1.0

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1783

0.97

0.14

2.9

1.4

4.17

4.20

g/l

0.27

151

1596

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

160

0.87

0.14

1.6

1.7

63.25

140.35

umol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

500

1.06

0.13

1.6

2.3

51.28

23.97

mg/l

1.25

167

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

0.82

0.13

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

386

0.93

0.12

1.8

1.7

33.00

25.45

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

147

1514

0.97

0.12

3.2

1.5

0.83

0.35

g/l

1.32

125

1306

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

116

0.86

0.12

4.7

1.7

252.20

177.74

—

110

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.14

0.11

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

270

0.93

0.10

1.8

1.9

97.62

115.19

ng/l

0.74

270

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.15

0.10

1.3

1.5

1.14

1.17

mmol/l

0.53

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

893

8851

1.01

0.10

1.7

1.8

25679811.21

27290760.65

pmol/l

0.03

736

7226

(40768443) Skin Pathology biopsy report

146

1496

0.97

0.09

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

114

0.88

0.09

4.9

7.7

5.82

5.12

kpa

—

114

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.06

0.09

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.09

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1021

10141

1.01

0.08

3.2

3.0

0.76

0.72

ug/l

0.36

707

6933

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.08

0.08

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

164

0.91

0.08

1.2

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1651

16577

0.99

0.07

2.2

2.4

75.62

78.66

nmol/l

3.91

1459

14625

(3024471) HLA-A [Type]

0.80

0.07

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

108

1.11

0.07

1.3

1.2

14.17

10.06

mm/h

0.30

108

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.03

0.07

2.4

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

194

0.93

0.07

1.0

1.2

147.17

137.86

nmol/l

0.21

194

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

147

1.09

0.07

1.8

2.1

88.88

96.27

0.39

138

(3010503) CD19 cells [#/volume] in Blood

122

0.90

0.07

1.0

1.9

105.00

140.37

e6/l

0.48

115

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

1044

0.98

0.07

3.4

3.3

0.74

0.83

nmol/l

1.98

857

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.88

0.06

1.6

2.2

0.81

0.86

ug/l

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

0.88

0.06

1.1

2.1

—

108521.69

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

455

1.03

0.05

1.2

1.3

209.21

277.78

u/ml

1.29

280

(3004588) Protein electrophoresis panel - Serum or Plasma

291

2932

0.99

0.04

2.7

1.5

—

(4024509) Urine culture

196

1940

1.01

0.04

2.4

2.0

—

(3008295) Osmolality of Serum or Plasma

391

0.97

0.03

1.3

1.4

274.16

276.86

mosm/kgh2o

0.41

290

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

1.07

0.02

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1.05

0.02

1.9

1.1

38.91

39.04

g/l

0.03

172

(3000034) Microalbumin [Mass/volume] in Urine

399

0.98

0.02

3.3

3.0

47.75

36.84

mg/l

0.32

299

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

208

0.96

0.02

3.0

4.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

238

0.97

0.02

1.6

1.3

1.12

1.22

nmol/l

0.19

174

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

539

0.98

0.02

1.1

147.42

409.48

iu/ml

0.34

100

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

1.07

0.02

1.0

1.6

1504.18

76.43

nmol/24h

0.49

103

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

647

0.99

0.01

1.5

1.4

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.06

0.01

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

486

0.99

0.00

1.1

1.2

—

43.22

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

454

1.01

0.00

1.1

1.2

—

(3016750) Collection duration of Urine

231

1.00

0.00

1.8

2.0

498.00

499.25

min

0.02

175

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

242

0.99

0.00

1.3

1.5

14.56

14.64

umol/l

0.02

219

(3028433) Virus identified in Specimen by Culture

1.02

0.00

1.3

1.1

—

(3017704) Immunofixation for Urine

227

1.01

0.00

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

145

1.03

0.00

1.3

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

118

1.02

0.00

2.6

3.2

23.84

22.04

mu/l

0.07

111

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

127

1266

1.00

0.00

1.5

1.6

22.85

22.76

u/ml

0.01

223

(3009214) Lutropin [Units/volume] in Serum or Plasma

607

1.00

0.00

1.4

17.63

8.47

u/l

2.93

483

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

833

1.00

0.00

1.3

1.2

188.57

352.40

titre

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

168

1675

1.00

0.00

2.9

1.4

2.97

2.89

g/l

0.57

146

1485

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

445

1.01

0.00

1.2

1.3

—

nmol/l

—

(4038314) Semen analysis, post vasectomy

0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.27

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.99

0.00

2.4

1.8

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.2

—

921.83

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

1.99

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1273.33

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.01

-0.00

2.4

2.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

377.60

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

25.88

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.71

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.03

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

2.80

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.97

-0.00

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3940.00

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.90

-0.00

1.0

1.1

—

24.84

—

(40757373) Influenza virus identified in Isolate

0.95

-0.00

1.3

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

148.62

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.90

-0.00

1.0

1.1

105.57

101.85

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.55

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_ADENO – Adenocarcinoma and papilloma adenocarcinoma of rectum

GWS hits: 14

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenocarcinoma and papilloma adenocarcinoma of rectum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adenocarcinoma and papilloma adenocarcinoma of rectum (C3_RECTUM_ADENO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints